[go: up one dir, main page]

AU2003281226A8 - Peptidomimetic compound useful as inhibitor of integrins - Google Patents

Peptidomimetic compound useful as inhibitor of integrins

Info

Publication number
AU2003281226A8
AU2003281226A8 AU2003281226A AU2003281226A AU2003281226A8 AU 2003281226 A8 AU2003281226 A8 AU 2003281226A8 AU 2003281226 A AU2003281226 A AU 2003281226A AU 2003281226 A AU2003281226 A AU 2003281226A AU 2003281226 A8 AU2003281226 A8 AU 2003281226A8
Authority
AU
Australia
Prior art keywords
integrins
inhibitor
compound useful
peptidomimetic compound
peptidomimetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003281226A
Other versions
AU2003281226A1 (en
Inventor
Domenico Alloatti
Giuseppe Giannini
Mauro Marzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of AU2003281226A1 publication Critical patent/AU2003281226A1/en
Publication of AU2003281226A8 publication Critical patent/AU2003281226A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003281226A 2002-07-09 2003-07-03 Peptidomimetic compound useful as inhibitor of integrins Abandoned AU2003281226A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2002A000370 2002-07-09
IT2002RM000370A ITRM20020370A1 (en) 2002-07-09 2002-07-09 PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR.
PCT/IT2003/000422 WO2004005328A2 (en) 2002-07-09 2003-07-03 Peptidomimetic compound useful as inhibitor of integrins

Publications (2)

Publication Number Publication Date
AU2003281226A1 AU2003281226A1 (en) 2004-01-23
AU2003281226A8 true AU2003281226A8 (en) 2004-01-23

Family

ID=11456401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003281226A Abandoned AU2003281226A1 (en) 2002-07-09 2003-07-03 Peptidomimetic compound useful as inhibitor of integrins

Country Status (3)

Country Link
AU (1) AU2003281226A1 (en)
IT (1) ITRM20020370A1 (en)
WO (1) WO2004005328A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE490976T1 (en) * 2004-10-30 2010-12-15 Univ Pais Vasco B-LACTAM-RGD CYCLOPEPTIDES WITH GAMMA (G) TURNS
CN103374056B (en) * 2012-04-20 2017-02-08 首都医科大学 1-Acetyl-beta-carboline-3-formyl amino-acid benzyl ester, and synthesis and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
US6482821B2 (en) * 1996-12-20 2002-11-19 Hoechst Aktiengellschaft Vitronectin receptor antagonists, their preparation and their use
US6235877B1 (en) * 1999-08-04 2001-05-22 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors

Also Published As

Publication number Publication date
ITRM20020370A0 (en) 2002-07-09
WO2004005328A2 (en) 2004-01-15
WO2004005328A3 (en) 2004-02-26
AU2003281226A1 (en) 2004-01-23
ITRM20020370A1 (en) 2004-01-09

Similar Documents

Publication Publication Date Title
AP1967A (en) Thiazolidinone compounds as inhibitors of Hyak3
EP1549316A4 (en) INHIBITORS OF TFGbeta
PL372198A1 (en) Heteroaryl compounds useful as inhibitors of gsk-3
EG25482A (en) Inhibitors
IL165887A0 (en) Novel tetrahydropyridine derivatives as renin inhibitors
AU2003302238A8 (en) 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
ZA200409686B (en) Bicyclic 6-aklylidene-penems as ?-lactamases inhibitors
PL371217A1 (en) Inhibitors of integrin alphavbeta6
GB0202080D0 (en) Detection of objects
IL164898A0 (en) Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
EP1531857A4 (en) Metalloproteinase inhibitors
GB0202187D0 (en) "Inhibitors"
AU2003281226A8 (en) Peptidomimetic compound useful as inhibitor of integrins
AU2003242559A8 (en) Alkylaminosiloxanes as corrosion inhibitors
IL166719A0 (en) Beta-lactamase inhibitor prodrug
EP1658274A4 (en) Inhibitors of cathepsin s
AU2003304374A8 (en) Peptide inhibitors of beta-lactamases
AU2003270357A8 (en) Inhibitors of fungal invasion
EP1677782A4 (en) Inhibitors of cathepsin s
GB0224049D0 (en) Removal of nitrogen compounds
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
TW580005U (en) Structure of compound packing
AU2003217354A8 (en) Synthesis of sulfamidates

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase